Home›Companies›Biotech & Pharma›Laurentide Therapeutics

Laurentide Therapeutics Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 28, 2026·Suggest an edit

About Laurentide Therapeutics

Laurentide Therapeutics is a private company based in Atlanta, Georgia, incorporated in 2026 in Delaware. It has reported $99,999 raised in one offering on Form D since September 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 20, 2026Sep 28, 2026$99,999of $100K target7$14,286EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Laurentide Therapeutics's Form D filed Sep 28, 2026.

HN
Horace Nalle
President and director

Sources

  1. SECLaurentide Therapeutics Inc. filing history